NOV 2 0 2003 KO 3323? 1 of L
510(X) SUMMARY
Common/Usual Name: Laser Instrument
Product Trade Name: _ Vari-Lase J.ascy Console
Classification Name: Lascr Surgical Instrument for usc in General and Plastic Surgery and in
Dermatology 21 CRR 878-4810 (Product Code GEX)
Manufacturer: Vascular Solutions, Inc.
2495 Xcnium Lane North
Minneapolis, Minnesota 55441
Establishment Registration: 2134812
Contact: Deborah Jensen
V. P., Regulatory Affairs, Clinical Affairs, and Quality Systems
(763) 656-4349 phone
(763) 656-4250 fax
Performance Standards: No performance standards have been developed undet section 514 for
this device, The laser console is in compliance with the standards
established in 21 CFR 1040.
Device Description: The VARI-LASE Laser is a semiconducter diode laser operating at 610
+ 20 nanometers,
: , Intended Use: The VARI-LASE laser is indicated for the treatment of varicose veins
and varicosities associated with superficial reflux of the Greater
Saphenous Vein.
Summary of Non-Clinical Testing has been conducted to verify the laser console is in compliance
Testing: with the following standards:
ENG60601-1 Medical Dlectrical Equipment - Part 1: General Requirements For
Safety” .
TN60601-1-1 Medical Electrical Equipment - Part 1: General Requirements For Safety
1: Collateral Standard: Safery Requirements For Medical Electrical
Systems
EN60601-2 Medical Electrical Equipment - Part 1-2: General Requirements For
Safety - CoJatcral Standard: Electromagnetic Compatibility Requicemcats And Tests
EN60601-1-4 Medical Electtical Equipment - Part 1-4. General Requirements For
Safery - Collateral Standard: Programmable Electrical Medical Systems
ENG60601-2-22 Medical Electrical Equipment - Part 2; Particular Requircments For
safety - Section 2.22: Specification For Diagnostic And Therapeutic
Laser Equipment
Predicate Devices: / Diomed 15/30 Plus Diomed, Inc. (1K023543)
Medart 425P/426 Laser Consoles (K991659)
Conclusions: The VARI-LASE Laser is substantially equivalent to the identified
predicate devices based on a comparison of the indications for use
and the technological characteristics.

spent
i € DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
%
"mn
Food and Drug Administration
9200 Corporate Boulevard
NOV 2 0 2003 Rockville MD 20850
Ms. Deborah Jensen
Vice President, Regulatory Affairs,
Clinical Affairs and Quality Systems

Vascular Solutions, Inc.
2495 Xenium Lane North
Minneapolis, Minnesota 55441
Re: K033237

Trade/Device Name: Vascular Solutions Vari-Lase™ Endovenous Laser Console

Regulation Number: 21 CFR 878.4810

Regulation Name: Laser surgical instrument for use in general and

plastic surgery and in dermatology

Regulatory Class: I

Product Code: GEX

Dated: September 30, 2003

Received: October 7, 2003
Dear Ms. Jensen:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug.
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration. listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class II (Special Controls) or class [1] (PMA). it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 - Ms. Deborah Jensen
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market. :
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801). please
contact the Office of Compliance at (301) 594-4659. Also. please note the regulation entitled.
“Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http://www. fda.gov/cdrh/dsma/dsmamain.hunl

Sincerely yours,

€ shia M. Wien. PhD ALD
Director
Division of General. Restorative
and Neurological Devices

Office of Device Evaluation

Center for Devices and Radiological Health
Enclosure

Indications for Use Statement
5140(k) Number: Ko? 33 A)"
Device Name: Vascular Solutions Vari-Lase™ Endovenous Laser Console
Indications for Use:
VARI-LASE is indicated for the treatment of vaticose veins and varicosities associated
with superficial reflux of the Greater Saphenous Vein.
ivision Sign-Off) ive
Division of General, Restorativ
and Neurological Devices
63383 /
51.0(k) Number

